Atherectomy Devices Market Analysis By Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2014 - 2025

  • ID: 4209700
  • Report
  • Region: America, Asia, Asia Pacific, Europe, North America, United States
  • 95 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Avinger Inc.
  • BARD Peripheral Vascular
  • Bayer AG
  • Cardinal Health (Cordis)
  • Medtronic plc.
  • Spectranetics
  • MORE
The global atherectomy devices market is expected to reach USD 894.69 million by 2025. The demand for atherectomy devices market is anticipated to boost over the forecast period due to rapidly rising incidence of target diseases such as peripheral artery disease.

New technologies and product approvals are expected to boost the market for orbital and laser atherectomy devices over the forecast period. For instance, in July 2016, Cardiovascular Systems Inc. submitted an application for approval to Pharmaceuticals and Medical Devices Agency (PMDA), Japan’s regulatory agency for pharmaceuticals and medical devices. The company intends to launch Diamondback 360 Coronary OAS Micro Crown in the region and is looking for potential distributors. This would be the company’s first international market entry and the approval procedure is yet to be completed.

Further Key Findings from the Study Suggest:

Directional atherectomy devices was the largest segment in terms of revenue in the year 2016. This can be attributed to their capability of collecting the shaved plaque in a collecting space, which reduces the risk of barotrauma, dissection, and neointimal hyperplasia.

Laser atherectomy devices is expected to the fastest growing segment over the next 8 years. Laser technique is perceived as to have more precision in plaque removal and cause fewer complications. It is also believed to result in lesser incidence of restenosis.

Geographically, North America held the largest market share in 2015 and is expected to maintain its position during the forecast period. A high prevalence of Peripheral Artery Diseases (PAD) in this region is one of the key reasons for high demand of atherectomy. Almost 8.5 million people suffer from PAD in the U.S., resulting in an annual economic burden of nearly USD 160 million.

Asia Pacific is anticipated to observe the fastest growth over the coming years. Improving economic conditions leading to increasing prevalence of lifestyle diseases, especially cardiovascular and peripheral, is the key reason for this growth.

Some of the key industry contributors are Boston Scientific Corporation, Cardiovascular Systems Inc., Medtronic (Covidien), Spectranetics, VOLCANO CORPORATION, Avinger Inc., Bayer AG, Straub Medical AG, ST. JUDE MEDICAL, BARD Peripheral Vascular, Cardinal Health (Cordis), and Terumo IS.
PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Avinger Inc.
  • BARD Peripheral Vascular
  • Bayer AG
  • Cardinal Health (Cordis)
  • Medtronic plc.
  • Spectranetics
  • MORE
1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

2 Executive Summary

3 Market Snapshot

4 Atherectomy Devices Market Variables, Trends & Scope
4.1 Market Segmentation and Scope
4.1.1 Market driver analysis
4.1.1.1 Increasing prevalence of target diseases
4.1.1.2 Preference to minimally invasive procedures
4.1.2 Market Restraint Analysis
4.1.2.1 Lack of level 1 evidence for atherectomy
4.1.2.2 Lack of technical training for the procedure
4.2 Penetration & Growth Prospects Mapping
4.3 Atherectomy Devices Market - PESTLE Analysis
4.4 Industry Analysis - Porter’s
4.5 Atherectomy Devices Market Competitive Landscape: Market Position Analysis (Based on Products, Regional Presence)

5 Atherectomy Devices: Type Estimates & Trend Analysis
5.1 Atherectomy Devices Market: Type Movement Analysis
5.2 Directional Atherectomy Devices
5.2.1 Directional Atherectomy Devices Market, 2014 - 2025 (USD Million)
5.3 Rotational Atherectomy Sevices
5.3.1 Rotational Atherectomy Market, 2014 - 2025 (USD Million)
5.4 Orbital Atherectomy Devices
5.4.1 Orbital Atherectomy Devices Market, 2014 - 2025 (USD Million)
5.5 Laser Atherectomy Devices
5.5.1 Laser Atherectomy Devices Market, 2014 - 2025 (USD Million)

6 Atherectomy Devices: Regional Estimates & Trend Analysis, by Type
6.1 Atherectomy Devices Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 U.S.
6.2.1.1 U.S. Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.2.2 Canada
6.2.2.1 Canada Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 UK
6.3.1.1 UK Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Germany Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.4.2 China
6.4.2.1 China Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.4.3 Japan
6.4.3.1 Japan Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 MEA Atherectomy Devices Market, 2014 - 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Atherectomy Devices Market, 2014 - 2025 (USD Million)

7 Competitive Landscape
7.1 Strategy Framework
7.1.1 Boston Scientific Corporation
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Cardiovascular Systems Inc.
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Medtronic plc.
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Spectranetics
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.1 Strategic initiatives
7.1.5 VOLCANO CORPORATION
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Avinger Inc.
7.1.6.1 Company overview
7.1.6.2 Financial performance
7.1.6.3 Product benchmarking
7.1.6.4 Strategic initiatives
7.1.7 Bayer AG
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Strategic initiatives
7.1.8 Straub Medical AG
7.1.8.1 Company Overview
7.1.8.2 Product benchmarking
7.1.8.3 Strategic initiatives
7.1.9 ST. JUDE MEDICAL
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Product benchmarking
7.1.10 BARD Peripheral Vascular
7.1.10.1 Company overview
7.1.10.2 Financial performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives
7.1.11 . Cardinal Health (Cordis)
7.1.11.1 Company overview
7.1.11.2 Financial performance
7.1.11.3 Product benchmarking
7.1.11.4 Strategic initiatives
7.1.12 Terumo Medical Corporation
7.1.12.1 Company overview
7.1.12.2 Financial performance
7.1.12.3 Product benchmarking
7.1.12.4 Strategic initiatives

List of Tables

Table 1 Atherectomy Devices-Comparison
Table 2 Patient Selection Criteria
Table 3 Patient Selection Criteria
Table 4 Patient Selection Criteria
Table 5 Medicare Outpatient Payments for Peripheral Atherectomy (2007 - 2011)
Table 6 North America Atherectomy Devices Market, by Region, 2014 - 2025 (USD Million)
Table 7 North America Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 8 U.S. Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 9 Code for arterial thrombectomy in lower limb arteries
Table 10 Canada Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 11 Europe Atherectomy Devices Market, by Region, 2014 - 2025 (USD Million)
Table 12 Europe Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 13 UK Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 14 Germany Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 15 Asia Pacific Atherectomy Devices Market, by Region, 2014 - 2025 (USD Million)
Table 16 Asia Pacific Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 17 China Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 18 Japan Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 19 Latin America Atherectomy Devices Market, by Region, 2014 - 2025 (USD Million)
Table 20 Latin America Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 21 Brazil Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 22 MEA Atherectomy Devices Market, by Region, 2014 - 2025 (USD Million)
Table 23 MEA Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)
Table 24 South Africa Atherectomy Devices Market, by Type, 2014 - 2025 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market summary
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Prevalence of PAD (%)
Figure 12 Volume of minimally invasive surgeries, 2005 - 2014 (Thousands)
Figure 13 Market restraint relevance analysis (Current &future impact)
Figure 14 Penetration & growth prospect mapping
Figure 15 Atherectomy devices market - PESTLE analysis
Figure 16 Porter’s Five Forces Analysis
Figure 17 Atherectomy devices: Heat map analysis
Figure 18 Atherectomy devices market type outlook key takeaways
Figure 19 Atherectomy devices: Type movement analysis
Figure 20 Global directional atherectomy devices market, 2014 - 2025 (USD Million)
Figure 21 Above knee atherosclerosis
Figure 22 Below knee atherosclerosis
Figure 23 Global rotational atherectomy market, 2014 - 2025 (USD Million)
Figure 24 Global orbital atherectomy devices market, 2014 - 2025 (USD Million)
Figure 25 Global laser atherectomy devices market, 2014 - 2025 (USD Million)
Figure 26 Regional Market Place: Key Takeaways
Figure 27 Regional outlook, 2016 & 2025
Figure 28 North America atherectomy devices market, 2014 - 2025 (USD Million)
Figure 29 U.S. atherectomy devices market, 2014 - 2025 (USD Million)
Figure 30 Canada atherectomy devices market, 2014 - 2025 (USD Million)
Figure 31 Europe atherectomy devices market, 2014 - 2025 (USD Million)
Figure 32 UK atherectomy devices market, 2014 - 2025 (USD Million)
Figure 33 Germany atherectomy devices market, 2014 - 2025 (USD Million)
Figure 34 Asia Pacific atherectomy devices market, 2014 - 2025 (USD Million)
Figure 35 China atherectomy devices market, 2014 - 2025 (USD Million)
Figure 36 Japan atherectomy devices Market, 2014 - 2025 (USD Million)
Figure 37 Latin America atherectomy devices market, 2014 - 2025 (USD Million)
Figure 38 Brazil atherectomy devices market, 2014 - 2025 (USD Million)
Figure 39 MEA atherectomy devices market, 2014 - 2025 (USD Million)
Figure 40 South Africa atherectomy devices market, 2014 - 2025 (USD Million)
Figure 41 Strategy framework
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Boston Scientific Corporation
  • Cardiovascular Systems Inc.
  • Medtronic plc.
  • Spectranetics
  • VOLCANO CORPORATION
  • Avinger Inc.
  • Bayer AG
  • Straub Medical AG
  • ST. JUDE MEDICAL
  • BARD Peripheral Vascular
  • Cardinal Health (Cordis)
  • Terumo Medical Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll